Clearmind Medicine Inc.
CMND | NASDAQ
$0.78
-$0.01 (-1.34%)
Sep 22, 2026, 12:01 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Oct 30, 2025 | FY 2024 Oct 30, 2024 | FY 2023 Oct 30, 2023 | FY 2022 Oct 30, 2022 | FY 2021 Oct 30, 2021 | FY 2020 Oct 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 49.36K | 51.07K | 57.43K | 119.62K | 2.53K | n/a |
Gross Profit | -49.36K | -51.07K | -57.43K | -119.62K | -2.53K | n/a |
Operating Income | -5.67M | -5.74M | -6.29M | -9M | -3.61M | -230.12K |
Interest Income | 132.9K | 271.22K | 59.09K | n/a | n/a | n/a |
Pretax Income | -3.79M | -4.88M | -8.59M | -9.89M | -3.66M | -230.12K |
Net Income | -3.86M | -5.25M | -8.61M | -9.93M | -3.66M | -230.12K |
Selling & General & Admin | 3.57M | 4.32M | 4.71M | 4.47M | 2.98M | 230.12K |
Research & Development | 2.05M | 1.37M | 1.53M | 4.42M | 635.4K | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 5.62M | 5.69M | 6.24M | 8.88M | 3.61M | 230.12K |
Interest Expense | 19.54K | 36.16K | n/a | 20.76K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.67M | 5.74M | 6.29M | 9M | 3.61M | 230.12K |
Income Tax Expense | 70.44K | 377.97K | 17.35K | 42.99K | n/a | n/a |
Shares Outstanding (Basic) | 1.27M | 775.03K | 50.62K | 10.83K | 7.73K | 4.53K |
Shares Outstanding (Diluted) | 1.27M | 775.03K | 50.62K | 10.83K | 7.73K | 4.53K |
EPS (Basic) | -3.03 | -6.78 | -170.07 | -916.44 | -473.10 | -50.76 |
EPS (Diluted) | -3.03 | -6.78 | -170.07 | -916.44 | -473.10 | -50.76 |
EBITDA | -3.72M | -4.79M | -8.53M | -9.75M | -3.65M | -230.12K |
EBIT | -3.77M | -4.84M | -8.59M | -9.86M | -3.66M | -230.12K |
Depreciation & Amortization | 49.36K | 51.07K | 57.43K | 119.62K | 2.53K | n/a |
Add to Watchlist
Select watchlists to add or remove CMND